2022
The Emergence and Dissemination of Multidrug Resistant Pseudomonas aeruginosa in Lebanon: Current Status and Challenges during the Economic Crisis
Dabbousi A, Dabboussi F, Hamze M, Osman M, Kassem I. The Emergence and Dissemination of Multidrug Resistant Pseudomonas aeruginosa in Lebanon: Current Status and Challenges during the Economic Crisis. Antibiotics 2022, 11: 687. PMID: 35625331, PMCID: PMC9137902, DOI: 10.3390/antibiotics11050687.Peer-Reviewed Original ResearchMultidrug-resistant Pseudomonas aeruginosaDiabetic foot infectionsChronic airway diseasesLesions of patientsAntimicrobial resistanceHealthcare-associated infectionsResistant Pseudomonas aeruginosaPublic health concernAntimicrobial susceptibility profilesFoot infectionsAirway diseaseNon-clinical settingsMechanical ventilationBurn patientsCommon causeHematological malignanciesAMR surveillance programsCarbapenem resistanceVariety of antimicrobialsHuman infectionsRecalcitrant infectionsSusceptibility profilesSurveillance programHealth concernInfection
2018
Epidemiology of antimicrobial resistance in Lebanese extra-hospital settings: An overview
Osman M, Al Mir H, Rafei R, Dabboussi F, Madec J, Haenni M, Hamze M. Epidemiology of antimicrobial resistance in Lebanese extra-hospital settings: An overview. Journal Of Global Antimicrobial Resistance 2018, 17: 123-129. PMID: 30553113, DOI: 10.1016/j.jgar.2018.11.019.Peer-Reviewed Original ResearchConceptsAntimicrobial resistanceExtra-hospital settingsTerms of mortalityMiracle drugAntimicrobial-resistant pathogensNon-clinical settingsSignificant morbidityClinical settingNovel drugsAntimicrobial-resistant bacteriaMultidrug-resistant bacterial strainsSocietal costsInappropriate useCombat infectionEpidemiological situationMorbidityMortalityEpidemiologyDrugsAntibioticsVeterinary medicineAMR crisisMajority of investigations